Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (1999) | Total Docs. (3years) | Total Refs. (1999) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (1999) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51 | Journal of Pharmacokinetics and Pharmacodynamics | journal | 0.820 Q1 | 70 | 32 | 108 | 792 | 202 | 103 | 1.12 | 24.75 |  |
| 52 | Anti-Cancer Drug Design | journal | 0.802 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 53 | Drug Safety | journal | 0.795 Q1 | 140 | 92 | 208 | 6358 | 598 | 202 | 2.83 | 69.11 |  |
| 54 | Cancer Chemotherapy and Pharmacology, Supplement | journal | 0.794 Q1 | 35 | 17 | 61 | 623 | 140 | 59 | 2.51 | 36.65 |  |
| 55 | European Neuropsychopharmacology | journal | 0.753 Q1 | 130 | 113 | 259 | 3632 | 462 | 256 | 2.88 | 32.14 |  |
| 56 | Investigational New Drugs | journal | 0.720 Q1 | 97 | 38 | 143 | 2490 | 301 | 142 | 2.01 | 65.53 | |
| 57 | Experimental and Clinical Psychopharmacology | journal | 0.719 Q1 | 101 | 53 | 143 | 2565 | 240 | 143 | 1.43 | 48.40 | |
| 58 | Journal of Lipid Mediators and Cell Signalling | journal | 0.717 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 59 | Canadian Journal of Physiology and Pharmacology | journal | 0.710 Q1 | 95 | 120 | 518 | 4841 | 761 | 516 | 1.41 | 40.34 |  |
| 60 | Chirality | journal | 0.707 Q1 | 83 | 124 | 307 | 2883 | 461 | 303 | 1.36 | 23.25 | |
| 61 | Antiviral Research | journal | 0.703 Q1 | 151 | 70 | 217 | 3183 | 441 | 216 | 1.98 | 45.47 | |
| 62 | Bulletin of Mathematical Biology | journal | 0.702 Q1 | 97 | 49 | 147 | 1824 | 169 | 147 | 1.18 | 37.22 | |
| 63 | Apoptosis : an international journal on programmed cell death | journal | 0.700 Q1 | 128 | 48 | 130 | 2463 | 202 | 130 | 1.44 | 51.31 | |
| 64 | Clinical Neuropharmacology | journal | 0.672 Q1 | 85 | 65 | 197 | 2155 | 419 | 187 | 1.91 | 33.15 | |
| 65 | Cytokines, Cellular and Molecular Therapy | journal | 0.670 Q1 | 28 | 26 | 56 | 1337 | 101 | 55 | 1.80 | 51.42 | |
| 66 | Perspectives in Drug Discovery and Design | journal | 0.664 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 67 | Tumor Targeting | journal | 0.664 Q1 | 10 | 32 | 22 | 1183 | 41 | 21 | 1.86 | 36.97 | |
| 68 | Indian Drugs | journal | 0.660 Q1 | 32 | 157 | 412 | 2354 | 229 | 392 | 0.58 | 14.99 |  |
| 69 | Therapeutic Drug Monitoring | journal | 0.660 Q1 | 102 | 105 | 372 | 2061 | 541 | 352 | 1.36 | 19.63 | |
| 70 | Progress in Medicinal Chemistry | journal | 0.657 Q1 | 38 | 7 | 20 | 1411 | 37 | 12 | 1.25 | 201.57 | |
| 71 | Journal of Cardiovascular Pharmacology | journal | 0.648 Q2 | 109 | 290 | 1023 | 9704 | 1608 | 1016 | 1.48 | 33.46 | |
| 72 | Drug Resistance Updates | journal | 0.642 Q2 | 132 | 51 | 56 | 3305 | 109 | 48 | 1.95 | 64.80 | |
| 73 | Cancer Chemotherapy and Pharmacology | journal | 0.636 Q2 | 122 | 163 | 470 | 4403 | 841 | 466 | 1.78 | 27.01 | |
| 74 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | journal | 0.632 Q2 | 150 | 96 | 275 | 3693 | 397 | 274 | 1.49 | 38.47 | |
| 75 | Journal of Veterinary Pharmacology and Therapeutics | journal | 0.624 Q2 | 67 | 55 | 234 | 1416 | 223 | 233 | 0.81 | 25.75 | |
| 76 | Journal of Clinical Pharmacology | journal | 0.611 Q2 | 130 | 157 | 461 | 4251 | 818 | 447 | 1.77 | 27.08 | |
| 77 | European Journal of Clinical Pharmacology | journal | 0.595 Q2 | 123 | 137 | 550 | 3310 | 923 | 510 | 1.63 | 24.16 | |
| 78 | Biomedical Chromatography | journal | 0.593 Q2 | 71 | 126 | 252 | 2064 | 265 | 250 | 0.96 | 16.38 | |
| 79 | Heterocycles | journal | 0.591 Q2 | 70 | 394 | 1177 | 10151 | 1145 | 1176 | 1.06 | 25.76 |  |
| 80 | Clinical and Experimental Pharmacology and Physiology | journal | 0.580 Q2 | 115 | 209 | 626 | 7197 | 887 | 625 | 1.27 | 34.44 | |
| 81 | Journal of Ocular Pharmacology and Therapeutics | journal | 0.578 Q2 | 72 | 59 | 170 | 1447 | 169 | 169 | 0.87 | 24.53 | |
| 82 | Immunopharmacology | journal | 0.565 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 83 | Clinical Therapeutics | journal | 0.550 Q2 | 150 | 187 | 406 | 5437 | 744 | 357 | 1.92 | 29.07 | |
| 84 | Modern Trends in Pharmacopsychiatry | journal | 0.535 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 |  |
| 85 | Inflammation Research | journal | 0.534 Q2 | 107 | 169 | 455 | 4310 | 642 | 449 | 1.33 | 25.50 | |
| 86 | Xenobiotica | journal | 0.534 Q2 | 89 | 93 | 297 | 3240 | 478 | 296 | 1.42 | 34.84 | |
| 87 | PharmacoEconomics | journal | 0.533 Q2 | 118 | 134 | 438 | 5226 | 626 | 403 | 1.41 | 39.00 | |
| 88 | Cardiovascular Drugs and Therapy | journal | 0.530 Q2 | 79 | 58 | 286 | 1868 | 335 | 255 | 1.02 | 32.21 | |
| 89 | Vascular Pharmacology | journal | 0.518 Q2 | 108 | 163 | 749 | 5521 | 894 | 746 | 1.17 | 33.87 | |
| 90 | Journal of Peptide Science | journal | 0.517 Q2 | 73 | 58 | 128 | 2119 | 150 | 128 | 1.26 | 36.53 | |
| 91 | European Journal of Medicinal Chemistry | journal | 0.515 Q2 | 203 | 107 | 306 | 3103 | 398 | 297 | 1.17 | 29.00 |  |
| 92 | Journal of Food Biochemistry | journal | 0.513 Q2 | 64 | 38 | 83 | 1154 | 61 | 83 | 0.69 | 30.37 | |
| 93 | Basic and Clinical Pharmacology and Toxicology | journal | 0.510 Q2 | 103 | 106 | 347 | 3874 | 427 | 344 | 1.11 | 36.55 | |
| 94 | Antiviral Chemistry and Chemotherapy | journal | 0.497 Q2 | 59 | 32 | 176 | 1616 | 306 | 175 | 1.79 | 50.50 | |
| 95 | Anti-Cancer Drugs | journal | 0.496 Q2 | 102 | 127 | 418 | 3493 | 725 | 410 | 1.83 | 27.50 | |
| 96 | Cytokines and Molecular Therapy | journal | 0.490 Q2 | 14 | 0 | 31 | 0 | 49 | 31 | 0.00 | 0.00 | |
| 97 | Journal of Biopharmaceutical Statistics | journal | 0.477 Q2 | 56 | 42 | 127 | 705 | 61 | 122 | 0.50 | 16.79 | |
| 98 | Metal-Based Drugs | journal | 0.474 Q2 | 40 | 47 | 106 | 1303 | 110 | 105 | 1.03 | 27.72 | |
| 99 | Japanese Journal of Pharmacology | journal | 0.471 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 100 | Phytomedicine | journal | 0.461 Q2 | 141 | 58 | 156 | 1070 | 143 | 156 | 0.70 | 18.45 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data